Browsing by Author "Gautam, Mahesh Kumar"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Publication Intravenous Immunoglobulin in Neonatal Sepsis(Nepal Paediatric Society (JNPS), 2013) Li, Jiang; Gautam, Mahesh KumarAbstract: Neonatal sepsis remains the major cause of mortality and morbidity including neurodevelopmental impairment and prolonged hospital stay in newborn infants. Despite of advances in technology and optimal antibiotic treatment, incidence of neonatal sepsis and its complications remains unacceptably high especially in developing countries. Premature neonates in particular are at higher risk due to developmentally immature host defense mechanisms. Though not approved by Food and Drug Administration (FDA) U.S.A, off label use of intravenous immunoglobulin continues in many countries. Recent evidences showed no significant decrease in the mortality rate or other outcomes when intravenous immunoglobulin is administered in addition to standard therapies. Hence, use of intravenous immunoglobulin in suspected or proven neonatal sepsis is not recommended. The expense of prophylactic use of intravenous immunoglobulin administration for both term and preterm newborn population, given the minimal benefit is not justified. Future studies are required which should focus on other prophylactic or adjuvant treatment modalities in addition to the standard therapy in neonatal sepsis.Publication Neonatal Candida Lusitaniae Septicemia(Nepal Paediatric Society (JNPS), 2014) Gautam, Mahesh Kumar; Li, JiangAbstract: Neonatal candidemia is an increasing cause of neonatal morbidity and mortality. Most reported cases are due to Candida albicans, but non-albicans species are on the rise. Candida lusitaniae is infrequently reported opportunistic pathogen. It causes serious and fatal infection. Early diagnosis and proper antifungal therapy can prevent morbidity and mortality in premature neonates.